Subscribe To
MDGEF / Medigene AG to Present Expitope 3.0 at the 20th Annual Meeting of the Association for Cancer Immunotherapy (CIMT)
MDGEF News
By GlobeNewsWire
September 11, 2023
Medigene AG to present at the Baader Investment Conference 2023
Planegg/Martinsried, September 11, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company f more_horizontal
By GlobeNewsWire
September 5, 2023
Medigene AG to present at the H.C. Wainwright 25th Annual Global Investment Conference
Planegg/Martinsried, September 5, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discove more_horizontal
By GlobeNewsWire
August 22, 2023
Medigene AG to present at the 8th CAR-TCR Summit in Boston
Planegg/ Martins ried , August 22 , 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the disco more_horizontal
By GlobeNewsWire
May 8, 2023
Medigene AG to present at upcoming investor conferences
Planegg/Martinsried, May 8, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and more_horizontal
By GlobeNewsWire
April 27, 2023
Medigene AG to Present Expitope 3.0 at the 20th Annual Meeting of the Association for Cancer Immunotherapy (CIMT)
Martinsried /M unich , April 27 , 202 3 . Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the disco more_horizontal
By Seeking Alpha
August 7, 2022
Medigene AG (MDGEF) Management on H1 2022 Results - Earnings Call Transcript
Medigene AG (OTCPK:MDGEF) H1 2022 Earnings Conference Call August 3, 2022 9:00 AM ET Company Participants Anna Niedl - Investor Relations Dolores Sche more_horizontal